• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A multi-center survey of achieving recommended lipid goals in Chinese patients with coronary artery disease in real world cardiovascular practice.

作者信息

Guo Yuan-Lin, Liu Jun, Li Jian-Jun, Zhu Cheng-Gang, Qing Ping, Jia Yan-Jun, Wu Na-Qiong, Nie Shao-Ping, Li Zi-Cheng, Zeng He-Song, Yang Ping

出版信息

Int J Cardiol. 2011 Dec 1;153(2):211-2. doi: 10.1016/j.ijcard.2011.09.028. Epub 2011 Oct 13.

DOI:10.1016/j.ijcard.2011.09.028
PMID:21996418
Abstract
摘要

相似文献

1
A multi-center survey of achieving recommended lipid goals in Chinese patients with coronary artery disease in real world cardiovascular practice.一项关于中国冠心病患者在真实世界心血管实践中实现推荐血脂目标情况的多中心调查。
Int J Cardiol. 2011 Dec 1;153(2):211-2. doi: 10.1016/j.ijcard.2011.09.028. Epub 2011 Oct 13.
2
Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study.根据 2016 年欧洲心脏病学会建议，冠状动脉钙测试对降脂治疗风险分层的影响：MESA 研究。
Eur J Prev Cardiol. 2018 Nov;25(17):1887-1898. doi: 10.1177/2047487318788930. Epub 2018 Jul 25.
3
[Lipid control in patients with coronary artery disease in a healthcare area in Cáceres (Spain): LIPICERES study].[西班牙卡塞雷斯某医疗区域冠心病患者的血脂控制：LIPICERES研究]
Clin Investig Arterioscler. 2017 Jan-Feb;29(1):13-19. doi: 10.1016/j.arteri.2016.09.003. Epub 2017 Jan 3.
4
Differences in clinical and angiographic profiles between Asian and Western patients with coronary artery disease: insights from the prospective "real world" paclitaxel-coated balloon registry.
Int J Cardiol. 2014 Jul 15;175(1):199-200. doi: 10.1016/j.ijcard.2014.04.239. Epub 2014 Apr 28.
5
Constructing a point-based prediction model for the risk of coronary artery disease in a Chinese community: a report from a cohort study in Taiwan.构建中国社区冠心病风险的基于点的预测模型：台湾一项队列研究的报告。
Int J Cardiol. 2012 May 31;157(2):263-8. doi: 10.1016/j.ijcard.2012.03.017. Epub 2012 Apr 12.
6
Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study.南美原住民提斯曼人中的冠状动脉粥样硬化：一项横断面队列研究。
Lancet. 2017 Apr 29;389(10080):1730-1739. doi: 10.1016/S0140-6736(17)30752-3. Epub 2017 Mar 17.
7
The effect of the intensity of lipid-lowering medications on the LDL cholesterol treatment goals of Asian patients with dyslipidaemia in primary care.降脂药物强度对基层医疗中血脂异常亚洲患者低密度脂蛋白胆固醇治疗目标的影响。
J Clin Pharm Ther. 2016 Dec;41(6):677-683. doi: 10.1111/jcpt.12447. Epub 2016 Sep 19.
8
No evidence to support high-intensity statin in Chinese patients with coronary heart disease.没有证据支持在中国冠心病患者中使用高强度他汀类药物。
Int J Cardiol. 2016 Feb 1;204:57-8. doi: 10.1016/j.ijcard.2015.11.164. Epub 2015 Nov 23.
9
Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies.尽管使用了大量的循证疗法，但在治疗伴有动脉粥样硬化性心血管疾病的糖尿病患者时，指南指导下的血脂目标仍未得到充分实现。
Diab Vasc Dis Res. 2012 Apr;9(2):138-45. doi: 10.1177/1479164111431471. Epub 2012 Jan 10.
10
Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.对在初级卫生保健机构就诊的沙特糖尿病患者心血管疾病风险因素的评估。
Diabetes Metab Syndr. 2013 Jul-Sep;7(3):133-7. doi: 10.1016/j.dsx.2013.06.012. Epub 2013 Jul 17.

引用本文的文献

1
Policosanol attenuates statin-induced increases in serum proprotein convertase subtilisin/kexin type 9 when combined with atorvastatin.当与阿托伐他汀联合使用时，植物甾醇可减轻他汀类药物引起的血清前蛋白转化酶枯草溶菌素/克那霉 9 升高。
Evid Based Complement Alternat Med. 2014;2014:926087. doi: 10.1155/2014/926087. Epub 2014 Nov 16.
2
Short-term impact of low-dose atorvastatin on serum proprotein convertase subtilisin/kexin type 9.低剂量阿托伐他汀对血清前蛋白转化酶枯草溶菌素9型的短期影响。
Clin Drug Investig. 2013 Dec;33(12):877-83. doi: 10.1007/s40261-013-0129-2.